This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_INSITU_SKIN_EYELID_EXALLC for full statistics.
Carcinoma in situ of skin of eyelid, including canthus
CD2_INSITU_SKIN_EYELID
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
65 |
4. Check minimum number of eventsNone |
65 |
5. Include endpointsNone |
65 |
6. Filter based on genotype QC (FinnGen only) |
65 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D04
- Name in latin
- Carcinoma in situ cutis palpebrae
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of skin of eyelid, including canthus
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of skin of eyelid, including canthus
- In situ neoplasms
- In situ neoplasms
- Neoplasms
- Any operation in hilmo
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 65 | 28 | 37 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.02 |
| Median age at first event (years) | 75.37 | 75.82 | 75.03 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 58
- Matched controls
- 577
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D04.1
ICD-10 Finland
Carcinoma in situ: Skin of eyelid, including canthus
+∞
80.4
57
*
CBA10
NOMESCO Finland
Biopsy of eyelid
54.6
11.5
13
*
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
24.6
11.0
15
8
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
133.1
10.8
11
*
CBB50
NOMESCO Finland
Excision of lesion of eyelid and reconstruction using graft or flap
133.1
10.8
11
*
L57.0
ICD-10 Finland
Actinic keratosis
7.6
10.2
27
59
TQW99
NOMESCO Finland
Other minor procedure on skin
12.5
10.0
18
20
CBB30
NOMESCO Finland
Excision of lesion of eyelid
37.0
9.8
12
*
D23.1
ICD-10 Finland
Benign neoplasm: Skin of eyelid, including canthus
19.0
7.6
11
7
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
6.2
6.8
19
42
C44.12
ICD-10 Finland
Spinocellular carcinoma of the skin of the eyelids including the corner of the eye
+∞
6.4
6
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
5.7
6.1
18
42
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768804) Tissue Pathology biopsy report
46
186
6.04
10.93
4.1
2.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
17
34
6.42
8.70
2.2
1.5
—
—
—
0
0
(3002256) Pathology report gross observation
22
58
5.22
8.36
1.9
1.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
30
106
4.40
7.87
2.5
1.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
11
24
5.31
4.99
3.3
1.9
—
—
—
0
0
(40768443) Skin Pathology biopsy report
10
20
5.73
4.95
1.0
1.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
34
173
3.02
4.60
10.3
5.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
19
70
3.42
4.39
1.9
1.6
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
14
42
3.97
4.33
1.6
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
19
72
3.32
4.18
1.9
1.7
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
33
174
2.82
4.06
5.9
4.1
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
42
252
2.88
4.03
10.5
5.4
e9/l
2.2
1.7
0.34
37
229
(3001604) Monocytes [#/volume] in Blood
41
247
2.79
3.84
10.7
5.3
e9/l
0.6
0.6
0.10
36
220
(3006315) Basophils [#/volume] in Blood
41
247
2.79
3.84
10.7
5.3
e9/l
0.0
0.0
0.06
36
222
(4035726)
14
48
3.44
3.56
1.1
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
37
219
2.60
3.48
2.4
2.3
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
41
256
2.63
3.44
11.0
5.5
e9/l
0.2
0.2
0.08
35
229
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
38
233
2.52
3.25
2.5
2.1
pmol/l
89.1
90.4
0.07
24
110
(3000991) Gas panel - Venous blood
13
45
3.36
3.24
5.3
7.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
23
113
2.60
3.11
3.2
1.9
—
—
—
0
0
(3019225) pH of Specimen
13
48
3.14
2.92
5.4
4.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
9
23
4.37
2.90
2.7
1.7
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
50
361
2.67
2.85
5.3
4.7
mm/h
20.2
15.2
0.79
44
326
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
39
254
2.34
2.77
8.9
5.8
mmol/l
1.2
1.2
0.16
33
222
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
7
15
5.09
2.67
1.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
7
15
5.09
2.67
1.4
1.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
57
456
3.03
2.66
31.4
18.3
mg/l
35.6
23.6
1.13
50
384
(3031040) Bacteria [#/volume] in Urine by Automated count
48
349
2.44
2.55
6.8
5.8
—
435.7
—
0
12
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
10
34
3.29
2.54
3.0
6.3
mmol/l
23.9
25.1
—
10
29
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
18
87
2.48
2.46
4.3
2.6
e6/l
0.6
1.1
0.44
12
53
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
9
28
3.56
2.41
1.3
2.2
g/l
1.3
1.5
—
9
22
(3020564) Creatinine [Moles/volume] in Serum or Plasma
58
475
3.05
2.39
33.3
21.4
umol/l
101.7
86.5
0.74
58
475
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
33
210
2.16
2.37
4.4
3.6
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
7
18
4.22
2.32
1.0
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
5
9
5.91
2.25
1.2
1.1
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
58
482
2.88
2.22
32.9
21.0
mmol/l
138.9
139.6
0.87
58
465
(3023103) Potassium [Moles/volume] in Serum or Plasma
58
484
2.84
2.21
33.8
20.9
mmol/l
4.0
4.0
0.21
58
466
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
39
271
2.10
2.17
3.7
2.8
u/l
49.5
52.7
0.13
32
249
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
9
31
3.20
2.17
3.1
5.4
mmol/l
24.6
25.1
—
9
31
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
10
5.31
2.11
2.0
1.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
30
191
2.06
2.09
2.7
3.5
mmol/l
2.4
2.3
0.43
25
158
(3049717) Cytology report of Urine Cyto stain
7
21
3.60
2.03
3.6
3.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
26
159
2.06
2.00
3.2
2.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
54
434
2.44
1.97
5.6
7.4
mmol/mol
39.5
41.7
0.85
48
396
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
50
391
2.21
1.93
10.8
7.3
u/l
81.7
78.3
0.37
45
367
(3003327) Ova and parasites identified in Stool by Light microscopy
5
12
4.41
1.86
1.4
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
53
427
2.31
1.85
28.3
18.2
ml/min/173m2
67.5
70.5
0.44
48
356
(3003458) Phosphate [Moles/volume] in Serum or Plasma
16
83
2.23
1.84
11.7
5.1
mmol/l
1.1
1.0
0.37
16
68
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
51
408
2.16
1.76
4.7
4.5
mmol/l
1.1
1.2
0.36
45
349
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
53
431
2.24
1.74
5.2
4.9
mmol/l
4.1
4.3
0.86
47
378
(3022313) Gas panel - Capillary blood
7
26
2.89
1.63
6.3
3.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
56
479
2.22
1.60
16.7
11.4
u/l
21.3
23.1
0.53
51
461
(3014007) Fractional oxyhemoglobin in Arterial blood
8
33
2.62
1.60
3.4
7.3
%
93.7
92.4
—
8
33
(36304419) Bacteria [Presence] in Urine
24
153
1.90
1.59
6.4
3.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
54
449
2.20
1.57
5.8
5.6
mmol/l
2.3
2.5
0.79
48
388
(3026493) Urate [Moles/volume] in Serum or Plasma
22
137
1.92
1.56
3.2
3.1
umol/l
394.7
2448.1
0.48
16
106
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
16
89
2.06
1.54
4.8
2.9
e6/l
0.5
1.3
—
10
55
(3021589) Normoblasts [#/volume] in Blood
31
218
1.81
1.50
14.3
11.3
e9/l
0.0
0.0
0.71
25
185
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
11
53
2.29
1.48
2.7
2.0
ng/l
334.5
227.8
0.29
11
44
(3012516) Albumin [Mass/volume] in Urine
23
151
1.81
1.37
3.2
2.8
mg/l
32.3
78.7
0.84
18
91
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
6
24
2.65
1.33
3.2
9.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
47
383
1.82
1.31
29.2
19.1
%
38.0
38.6
0.13
28
233
(3000494) Fungus identified in Specimen by Culture
11
56
2.16
1.31
1.5
1.5
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
24
162
1.76
1.30
6.5
3.3
e6/l
0.1
0.3
1.04
19
125
(3013512) EKG study
25
171
1.75
1.29
4.9
5.0
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
51
427
1.90
1.29
5.3
5.0
mmol/l
1.4
1.4
0.36
45
370
(3028026) IgM [Mass/volume] in Serum or Plasma
6
25
2.54
1.27
2.3
1.5
g/l
0.6
1.3
—
6
20
(3007853) Bacteria identified in Skin by Aerobe culture
10
50
2.18
1.24
3.2
1.6
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
28
202
1.68
1.18
3.8
3.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
24
166
1.71
1.18
3.5
3.7
mg/mmol
5.8
11.3
0.71
19
101
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
20
2.62
1.17
1.0
1.0
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
29
212
1.66
1.16
5.7
3.4
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
10
52
2.09
1.13
3.0
7.0
g/l
115.6
121.8
—
10
52
(3042936) Bacteria identified in Isolate by Culture
13
75
1.92
1.13
2.1
1.6
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
18
118
1.73
1.05
3.3
4.1
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
5
22
2.37
1.05
1.4
1.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
28
207
1.62
1.05
7.1
4.3
e6/l
46.3
86.3
0.50
20
155
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
49
417
1.71
1.03
4.6
4.9
mu/l
2.0
2.0
0.06
44
358
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
7
37
2.00
0.97
1.7
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
6
27
2.34
0.96
2.8
2.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
43
361
1.56
0.89
8.3
5.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
8
47
1.80
0.84
1.1
1.3
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
23
171
1.53
0.81
2.4
2.3
u/l
55.3
61.2
0.29
18
159
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
10
59
1.82
0.81
5.0
10.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
0
24
0.00
0.81
0.0
5.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
5
23
2.27
0.78
5.2
2.0
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
13
85
1.66
0.76
4.7
2.5
%
19.8
21.8
0.26
13
71
(3004789) Transferrin [Mass/volume] in Serum or Plasma
13
86
1.64
0.73
4.5
2.4
g/l
2.2
2.2
0.02
13
73
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
7
42
1.75
0.71
1.1
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
5
28
1.85
0.67
1.4
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
52
470
1.53
0.63
27.8
16.9
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
11
73
1.61
0.61
1.1
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
6
34
1.84
0.60
2.8
2.9
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
24
190
1.42
0.60
6.6
3.6
e6/l
8.8
353.6
0.52
17
148
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
0
23
0.00
0.59
0.0
2.1
—
4.4
—
0
18
(3002032) Base excess in Venous blood by calculation
9
59
1.61
0.58
4.9
4.1
mmol/l
-0.5
2.3
—
9
44
(3012544) pH of Venous blood
9
62
1.52
0.56
4.9
3.9
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
27
223
1.36
0.52
11.8
10.4
inr
1.3
1.3
—
5
76
(3004588) Protein electrophoresis panel - Serum or Plasma
7
46
1.58
0.50
1.1
2.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
49
446
1.40
0.49
5.9
5.4
mmol/l
6.0
6.1
0.15
43
388
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
7
48
1.51
0.49
1.1
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
13
96
1.44
0.46
7.7
5.4
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
33
1.56
0.42
1.2
2.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
0
15
0.00
0.42
0.0
1.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
0
15
0.00
0.42
0.0
2.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
18
144
1.35
0.41
8.4
7.0
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
5
35
1.46
0.40
4.0
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
5
35
1.46
0.40
2.4
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
6
42
1.47
0.37
2.5
3.9
—
—
—
0
0
(3003338) MCHC [Mass/volume]
39
354
1.25
0.33
36.3
23.9
g/l
329.6
330.4
0.21
39
349
(3041096) Erythrocytes [Presence] in Urine by Automated
12
150
0.75
0.31
5.3
4.7
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
7
55
1.31
0.31
4.7
4.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
27
238
1.23
0.29
6.1
4.7
ng/l
32.3
34.4
0.11
21
192
(1761868) Lipid panel - Serum or Plasma
10
127
0.75
0.29
3.4
4.0
—
—
—
0
0
(3000492) Spirometry study
5
38
1.34
0.24
1.6
1.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
18
207
0.82
0.23
4.5
5.0
—
—
—
0
0
(4010399)
5
40
1.27
0.23
1.6
1.3
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(1002224) Polysomnography panel
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
0
13
0.00
0.21
0.0
1.9
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
11
90
1.27
0.21
2.6
1.8
s
29.6
30.0
0.12
11
83
(3027945) Reticulocytes/100 erythrocytes in Blood
10
82
1.26
0.18
2.2
3.0
%
1.6
1.7
—
10
70
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
16
143
1.16
0.13
5.0
2.9
u/l
35.0
32.9
0.20
16
135
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
8
77
1.04
0.07
1.0
1.2
iu/ml
—
49.0
—
0
25
(3044889) 12 lead EKG panel
35
338
1.08
0.06
5.3
4.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
17
159
1.09
0.06
3.8
4.2
%
22.8
21.7
0.11
12
72
(3003694) ABO and Rh group [Type] in Blood
11
106
1.05
0.00
1.2
1.3
—
—
—
0
0
(4306422)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(44806118)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806420)
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
(44790047)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.5
—
428.7
—
0
6
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
0
6
0.00
0.00
0.0
5.7
—
37.5
—
0
6
(3000764) Benzodiazepines [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
6.2
—
0
6
(44790049)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
6
0.00
0.00
0.0
4.0
—
—
—
0
0
(44790048)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
3.8
—
61.0
—
0
5
(3023511) Choriogonadotropin [Units/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
5
0.00
0.00
0.0
4.8
—
57.2
—
0
5
(3023323) Follitropin [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
15.9
—
0
5
(3026389) Candida sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
5
0.00
0.00
0.0
1.8
—
30.4
—
0
5
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
5
49
1.02
0.00
2.6
1.7
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
0
5
0.00
0.00
0.0
2.4
—
6.0
—
0
5
(3004616) Nuclear Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
0
9
0.00
0.00
0.0
3.3
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_SKIN_EYELID – Carcinoma in situ of skin of eyelid, including canthus
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).